Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 403
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02003703 | Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . | ||
| NCT01076023 | Cohort Study in Type 2 Diabetes in China | ||
| NCT04462276 | Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease | ||
| NCT01426880 | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer | ||
| NCT05966233 | R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT04341181 | ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling | ||
| NCT00457301 | Using Health-related Quality of Life (HRQL) in Routine Clinical Care | ||
| NCT01745965 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. | ||
| NCT00394992 | Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer | ||
| NCT01457144 | Study of Mantle Cell Lymphoma Treatment by RiBVD | ||
| NCT05396937 | Efficacy and Safety of T+A+RAD in HCC | ||
| NCT05765084 | Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma | ||
| NCT00438152 | Lopinavir Capsules to Kaletra or Invirase Tablets | ||
| NCT06068998 | Molecular Characterization of Penile Cancers in Developing Countries | ||
| NCT02676947 | A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension | ||
| NCT04661358 | Fenofibrate for Prevention of DR Worsening | ||
| NCT01690325 | Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON) | ||
| NCT01697267 | Rituximab Vasculitis Maintenance Study | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT02814487 | MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment. | ||
| NCT01817452 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol | ||
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | ||
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer | ||
| NCT00485589 | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | ||
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | ||
| NCT02499003 | GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma | ||
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab | ||
| NCT01752192 | Teledi@Log - Tele-rehabilitation of Heart Patients | ||
| NCT05300282 | Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients | ||
| NCT00264290 | Valganciclovir to Reduce T Cell Activation in HIV Infection | ||
| NCT04387994 | Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF. | ||
| NCT01332929 | Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis | ||
| NCT05008081 | The CATALINA Study | ||
| NCT00170170 | Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation | ||
| NCT02389283 | Reduced Ultrasound Counts in Rheumatoid Arthritis | ||
| NCT00391248 | Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) | ||
| NCT02323555 | Optimize the Requirements and Preparations in Outpatient Chemotherapy | ||
| NCT04888221 | Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement | ||
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | ||
| NCT02626845 | Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis | ||
| NCT04611867 | Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) | ||
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | ||
| NCT00275665 | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. | ||
| NCT01048879 | Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD) | ||
| NCT02064491 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | ||
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT03961698 | Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma | ||
| NCT06008691 | A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice | ||
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC | ||
| NCT01240889 | Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges* |
